| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.36 | 0.004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |